dexfenfluramine has been researched along with Hypoxia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antier, D; Apfeldorfer, CS; Desbuards, N; Hanton, G; Hyvelin, JM; Rochefort, GY; Schenck, E | 1 |
| Callebert, J; Drouet, L; Etienne, N; Hervé, P; Humbert, M; Launay, JM; Maroteaux, L; Nebigil, CG; Peoc'h, K; Simonneau, G; Tournois, C | 1 |
| Antier, D; Bonnet, P; Eder, V; Hanton, G; Hyvelin, JM; Lemaire, MC; Rochefort, GY | 1 |
| Esteve, JM; Kellermann, O; Launay, JM; Maroteaux, L | 1 |
| Bader, M; Dempsie, Y; Harmar, A; Herold, N; Loughlin, L; MacLean, MR; MacRitchie, NA; Morecroft, I; Nilsen, M; Peacock, AJ; Welsh, DJ | 1 |
| Archer, SL; Dall'ava-Santucci, J; Dinh-Xuan, AT; Djaballah, K; Fartoukh, M; Humbert, M; Mercier, JC; Simonneau, G; Weir, KE | 1 |
1 review(s) available for dexfenfluramine and Hypoxia
| Article | Year |
|---|---|
Functions of serotonin in hypoxic pulmonary vascular remodeling.
Topics: Angiotensin II; Animals; Cell Division; Dexfenfluramine; Endothelium, Vascular; Gene Expression Regulation; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Models, Biological; Nitric Oxide; Oxygen; Protein Structure, Tertiary; Serotonin; Signal Transduction | 2007 |
5 other study(ies) available for dexfenfluramine and Hypoxia
| Article | Year |
|---|---|
Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: consequences on pulmonary hypertension.
Topics: Animals; Appetite Depressants; Dexfenfluramine; Enzyme Activation; Female; Gene Expression Regulation; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Lung; Rats; Rats, Wistar; rho-Associated Kinases; rhoA GTP-Binding Protein; RNA, Messenger; Signal Transduction; Weight Gain | 2009 |
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension.
Topics: Animals; Blood Pressure; Cell Division; Dexfenfluramine; Disease Models, Animal; DNA; Female; Humans; Hypertension, Pulmonary; Hypoxia; Lung; Male; Mice; Organ Culture Techniques; Pulmonary Artery; Pyrimidines; Receptor, Serotonin, 5-HT2B; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Vasoconstriction | 2002 |
Dexfenfluramine does not worsen but moderates progression of chronic hypoxia-induced pulmonary hypertension.
Topics: Animals; Blood Pressure; Body Weight; Chronic Disease; Dexfenfluramine; Disease Progression; Female; Heart Valve Diseases; Hypertension, Pulmonary; Hypoxia; Lung; Myocardium; Organ Size; Rats; Rats, Wistar; Serotonin Receptor Agonists; Ultrasonography, Doppler; Ventricular Function, Left; Ventricular Function, Right; Weight Gain | 2006 |
Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice.
Topics: Animals; Dexfenfluramine; Hypertension, Pulmonary; Hypoxia; Mice; Mice, Transgenic; p38 Mitogen-Activated Protein Kinases; Serotonin; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Tryptophan Hydroxylase | 2008 |
Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension.
Topics: Adult; Aged; Angina Pectoris; Appetite Depressants; Case-Control Studies; Dexfenfluramine; Disease Susceptibility; Female; Fenfluramine; Free Radical Scavengers; Humans; Hypertension; Hypertension, Pulmonary; Hypoxia; Ischemic Attack, Transient; Lung; Male; Middle Aged; Nitric Oxide; Oxidation-Reduction; Physical Exertion; Prospective Studies; Rest; Vascular Resistance | 1998 |